MyFinsight
Home
Blog
About
Back
Cash Flow
CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (CNSP)
source: myfinsight.com
Proceeds from sale of
common stock and...
$21,208,000
Net cash provided by
financing activities
$20,577,340
(44.37%↑ Y/Y)
Canceled cashflow
$136,782
Net change in cash
and cash...
$17,034,137
(200.51%↑ Y/Y)
Canceled cashflow
$3,543,203
Payments on notes payable
$90,782
(-48.36%↓ Y/Y)
Payments of deferred
offering costs
$46,000
Depreciation
$11,132
(405.77%↑ Y/Y)
Stock-based compensation
$2,445
(-97.10%↓ Y/Y)
Net cash used in
operating activities
-$3,539,382
(58.77%↑ Y/Y)
Net cash used in
investing activities
-$3,821
Canceled cashflow
$13,577
Net loss
-$2,587,954
(61.24%↑ Y/Y)
Accounts payable and
accrued expenses
-$611,795
(34.54%↑ Y/Y)
Prepaid expenses and
other current assets
$353,210
(-66.70%↓ Y/Y)
Purchase of property and
equipment
$3,821
Back